The results from Gunn Signe Jakobsen‘s PhD thesis show that bariatric surgery can improve obesity-related comorbidities more, but is also associated with higher complication rates than specialized medical treatment.


  1. Earlier onset of obesity, but not obesity-related comorbidities, predicts obese patients who will choose surgery rather than conservative treatment.
  2. Patients using the cholesterol-lowering drug atorvastatin should be monitored closely for both therapeutic and adverse effects following bariatric surgery.
  3. Hypertension, diabetes and dyslipidemia improved more following bariatric surgery than medical obesity treatmeant, but rates of complication were higher.


Thesis: Bariatric surgery and specialized medical treatment for severe obesity Impact on cardiovascular risk factors and postsurgical pharmacokinetics of atorvastatin
Candidate: Gunn Signe Jakobsen
Time: May 4, 2018 at 13:15
Place: Oslo University Hospital, Rikshospitalet B: Seminar room 3
Link to university website (in Norwegian)


(1) Lower age, higher BMI, and onset of obesity before 12 years of age were the only significant predictors of surgery as treatment choice in morbidly obese patients. 249 patients who underwent bariatric surgery were compared to 256 patients treated conservatively. Gender and cardiovascular comorbidities such as dyslipidemia, hypertension and diabetes did not influence treatment choice.

(2) The uptake of atorvastatin increased the first weeks following bariatric surgery, but normalized during the next two years. The study enrolled only 20 patients, but the findings still indicate that patients using atorvastatin or similar drugs should be monitored closely for both therapeutic effects and adverse events the first years after bariatric surgery.

(3) Surgically treated patients were more likely to quit medication for hypertension, diabetes and dyslipidemia, compared to patients treated conservatively. However, the risk of undergoing at least one additional gastrointestinal surgical procedure, the risk of treatment with opioids and the risk of new-onset depression were increased in the surgical group.

1888 patients were included in this study, and they were followed for a median of 6.5 years.


(1) Jakobsen, G. S., Hofsø, D., Røislien, J., Sandbu, R., & Hjelmesæth, J. (2010). Morbidly obese patients—who undergoes bariatric surgery?Obesity surgery20(8), 1142-1148.

(2) Jakobsen, G. S., Skottheim, I. B., Sandbu, R., Christensen, H., Røislien, J., Åsberg, A., & Hjelmesæth, J. (2013). Long-term effects of gastric bypass and duodenal switch on systemic exposure of atorvastatinSurgical endoscopy27(6), 2094-2101.

(3) Jakobsen, G. S., Småstuen, M. C., Sandbu, R., Nordstrand, N., Hofsø, D., Lindberg, M., Hertel, J. K., & Hjelmesæth, J. (2018). Association of Bariatric Surgery vs Medical Obesity Treatment With Long-term Medical Complications and Obesity-Related ComorbiditiesJama319(3), 291-301.

Latest News

May 28, 2024

Photos from the workshop on Advancing Ischemic Heart Disease Research

Approximately 25 researchers met in Trondheim for the new workshop called “Advancing Ischemic Heart Disease…

Read more
May 14, 2024

Photos from Course in Cardiac Mechanics 2024

Cardiac researchers and clinical cardiologists need to know key concepts and terms for measuring and describing…

Read more
April 28, 2024

Professor Kristina H. Haugaa receives the 2024 Heart Research Award

The Norwegian Health Association has awarded the prestigious 2024 Heart Research Award (Hjerteforskningsprisen) to professor Kristina…

Read more
September 08, 2023

Annual Symposium 2023: Winners and photos

More than 100 participants attended the 21st Annual Norwegian Symposium on Heart Research, hosted by…

Read more
Norheart uses cookies for analytical purposes, content and ads customisation, and to further develop our services.
Learn more
Show again